These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 10494333)

  • 21. A comparative study of QT prolongation with serotonin reuptake inhibitors.
    Ojero-Senard A; Benevent J; Bondon-Guitton E; Durrieu G; Chebane L; Araujo M; Montastruc F; Montastruc JL
    Psychopharmacology (Berl); 2017 Oct; 234(20):3075-3081. PubMed ID: 28770276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
    Vinnikova MA; Severtsev VV; Komarov SD; Vdovin AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2021; 121(12):57-62. PubMed ID: 35041313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Response to SSRI-induced enuresis: a case report.
    Ibrahim Ramadan M; Khan AY; Weston WE
    J Clin Psychopharmacol; 2006 Feb; 26(1):98-9. PubMed ID: 16415720
    [No Abstract]   [Full Text] [Related]  

  • 24. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
    Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
    Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
    Price JS; Waller PC; Wood SM; MacKay AV
    Br J Clin Pharmacol; 1996 Dec; 42(6):757-63. PubMed ID: 8971432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin reuptake inhibitor withdrawal.
    Coupland NJ; Bell CJ; Potokar JP
    J Clin Psychopharmacol; 1996 Oct; 16(5):356-62. PubMed ID: 8889907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. More cases of paroxetine withdrawal syndrome.
    Pacheco L; Malo P; Aragues E; Etxebeste M
    Br J Psychiatry; 1996 Sep; 169(3):384. PubMed ID: 8879736
    [No Abstract]   [Full Text] [Related]  

  • 28. Withdrawal syndromes after paroxetine and sertraline discontinuation.
    Fava GA; Grandi S
    J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
    [No Abstract]   [Full Text] [Related]  

  • 29. Serotonin syndrome caused by minimum doses of SSRIS in a patient with spinal cord injury.
    Satoh K; Takano S; Onogi T; Ohtsuki K; Kobayashi T
    Fukushima J Med Sci; 2006 Jun; 52(1):29-33. PubMed ID: 16995352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. By the way, doctor. My physician prescribed Celexa for me three years ago when I was upset over a family problem. I'm feeling better, and my situation has changed. I'd like to get off the medication. How do I do that?
    Harv Womens Health Watch; 2007 Jan; 14(5):8. PubMed ID: 17310511
    [No Abstract]   [Full Text] [Related]  

  • 31. [Differential features of SSRIs].
    Cervera S
    Rev Med Univ Navarra; 1997; 41(4):245-57. PubMed ID: 10420965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal complications after intrauterine exposure to SSRI antidepressants.
    Prescrire Int; 2004 Jun; 13(71):103-4. PubMed ID: 15233148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olanzapine and serotonin toxicity.
    Isbister GK; Downes F; Whyte IM
    Psychiatry Clin Neurosci; 2003 Apr; 57(2):241-2. PubMed ID: 12667176
    [No Abstract]   [Full Text] [Related]  

  • 34. Restlessness related to SSRI withdrawal.
    Hirose S
    Psychiatry Clin Neurosci; 2001 Feb; 55(1):79-80. PubMed ID: 11235863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
    Alfaro CL; Lam YW; Simpson J; Ereshefsky L
    J Clin Psychopharmacol; 1999 Apr; 19(2):155-63. PubMed ID: 10211917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin syndrome and fluvoxamine: a case study.
    Bastani JB; Troester MM; Bastani AJ
    Nebr Med J; 1996 Apr; 81(4):107-9. PubMed ID: 8628448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors.
    Frost L; Lal S
    Am J Psychiatry; 1995 May; 152(5):810. PubMed ID: 7726327
    [No Abstract]   [Full Text] [Related]  

  • 38. [Tourette's syndrome and antidepressant therapy: exacerbation of nervous tics with paroxetine].
    Rüth U; Mayer-Rosa J; Schlamp D; Freisleder FJ
    Z Kinder Jugendpsychiatr Psychother; 2000 May; 28(2):105-8. PubMed ID: 10863766
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similar discontinuation symptoms for withdrawal from medium-dose paroxetine and venlafaxine after nine years in the same patient.
    Kotzalidis GD; de Pisa E; Patrizi B; Savoja V; Ruberto G; Girardi P
    J Psychopharmacol; 2008 Jul; 22(5):581-4. PubMed ID: 18208915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
    Redrobe JP; Bourin M
    Psychopharmacology (Berl); 1998 Jul; 138(2):198-206. PubMed ID: 9718290
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.